+91 22 67261000
info@guficbio.com
Toggle navigation
Home
About Us
Overview
GUFIC Group
Operations
R & D
Quality
Plants and Facilities
Contract Manufacturing
Bulk Drugs
Marketing and Sales
India
Spark
Criticare
Herbal
Ferticare
International
GUFIC STRIDDEN
Products
Pharmaceutical
Spark
Criti Care
Ferticare
Herbal
API / Bulk Drugs
Personal care
International
Investors
Disclosures under Regulation 46
of the SEBI (LODR) Regulations,
2015
Details of Business
Corporate Governance
Composition of board
Corporate Governance Reports
Secretarial Compliance Report
Shareholding pattern
Codes/Policies
Regulation 30
Credit Rating
Newspaper Advertisement
General Meeting
Notices
Annual Reports
Business Responsibility Report
Annual Return
E-voting Results
Postal Ballot
Quarterly results
Board Meeting
Intimation & Outcome
Notices
Financial Statement of Subsidiaries
Gufic UK Limited
Investors Services
Company Secretary & Compliance Officer
Investor communications
Investor Grievance Report
Investors Redressal
Event based Compliances
Scheme Of Amalgamation
Reclassification of Share
UPDATES
Investor/Analyst Meeting
Related Party Transaction
Gufic IEPF
Environmental Compliance
Updates
MOA & AOA
Trading Window Closure
Other Policies
EQUAL OPPOURTUNITY POLICY
HUMAN RIGHTS POLICY
CODE OF CONDUCT – STAKEHOLDERS
ANTI – CORRUPTION & ANTI-FRAUD POLICY
Media
Life @ Gufic
Events @ Gufic
Gufic in the News
Careers
Contact
Investor Services
PROSIL-500-(TAB) Details
[<< Back]
